Sudarshan Pharma Industries Limited held its 18th Annual General Meeting (AGM) on Tuesday, 22nd September 2026 at 3:00 PM through Video Conferencing / Other Audio Visual Means. The meeting was conducted in compliance with circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India.
Mr. Hemal Mehta, Chairman & Managing Director of the Company, chaired the AGM. The Company Secretary introduced all Directors present, Chief Financial Officer, Company Secretary & Compliance Officer, Statutory Auditors, and Secretarial Auditors & Scrutinizer attending through VC/OAVM.
The Chairman addressed members with an overview of the present business and expansion & growth strategy. Mr. Sachin Mehta, Joint Managing Director, informed members about the financial performance and other operations during financial year 2025-26.
The following business items were transacted as per the Notice of AGM dated Wednesday, 12th August, 2026:
1. Adoption of audited standalone financial statements (including consolidated financial statements) of the Company for the financial year ended 31st March, 2026 together with Reports of the Board of Directors and Auditors thereon (Ordinary Resolution)
2. Appointment of a director in place of Dr. Anil Ghogare (DIN: 00432659), who retires by rotation and being eligible, offers himself for re-appointment (Ordinary Resolution)
The Company provided e-voting facilities to members, which remained available for 15 minutes after conclusion of the AGM. Mr. Vishal Mansita, Practicing Company Secretary, was appointed as Scrutinizer to scrutinize remote e-voting and e-voting at the AGM.
The consolidated results of voting will be declared within two working days of conclusion of the AGM upon receipt of the Scrutinizer's Report. The results will be communicated to BSE Limited and made available on the Company's website www.sudarshanpharma.com.
The AGM concluded with a vote of thanks to the Chair at 3:20 PM.